LBI-HTA - Publications - Search - Person: Zorginstituut Nederland (ZIN), EUnetHTA
Number of items: 1.

Zorginstituut Nederland (ZIN), EUnetHTA and Belgian Health Care Knowledge Centre (KCE), EUnetHTA (2018): MammaPrint® Added value of using the gene expression signature test MammaPrint® for adjuvant chemotherapy decision-making in early breast cancer. EUnetHTA report . HTA-Projektbericht 102.

This list was generated on Tue Jan 28 05:02:07 2020 CET.